P3 Health (PIII): Bozor kapitallashuvining kelajakdagi daromadga nisbati
P3 Health Partners Inc. (PIII) kompaniyasining oldingi P/S koeffitsiyenti tebranishlarni namoyish etmoqda, chunki AQSh ichki bozoridagi talab global xomashyo ta'minoti zanjirining uzilishlari xavfi bilan muvozanatlashmoqda. Joriy holat 0.00 hisoblanadi. Biznes sug'urta fondlari orqali nafaqexo'rlarga yordamni muvofiqlashtirishga tayanadi, biroq keksalar parvarishi yuqori xarajatlari kompaniyani moliyaviy holatini barqarorlashtirish uchun o'zining andersrayting modelini tubdan qayta ko'rib chiqishga majbur qilmoqda.
%20Forvard%20P%2FS%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_PIII_-_P3-Health-Partners-Inc._-_Forward-PS-Multiple "Forvard P/S multiplikatori: P3 Health Partners (PIII) 04.07.2022 - 13.11.2026 uchun | 👁️GURU.Markets👁️")
p3hp.org (PIII) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning kapitalga nisbati P3 Health Partners Inc.|PIII - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati P3 Health Partners|PIII - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati P3 Health Partners Inc.|PIII - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar P3 Health Partners|Tezkor likvidlik koeffitsiyenti p3hp.org
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
PIII - Kompaniyaning sof foydasi|Kutilayotgan sof daromad P3 Health Partners Inc.|PIII - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati P3 Health Partners|PIII - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati P3 Health Partners Inc.|PIII - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda P3 Health Partners|PIII - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi p3hp.org|PIII - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi P3 Health Partners Inc.
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:PIII, P3 Health
Investorlar uchun P3 Health Partners Inc. (PIII) kompaniyasining baholanishi, qat'iy CMS stavkalari tartibga solish choralari sharoitida Value-Based Care ekotizimining o'z Medicare Advantage tarmog'ini kengaytirish qobiliyatiga bog'liq. Forward P/S grafigini tahlil qilish orqali, aktiv haddan tashqari qimmat baholanganini aniqlash yoki g'ayritabiiy past multiplikator qiymatlari orqali kritik operatsion xatarlarni identifikatsiya qilish uchun kompaniyaning bozor qiymatini kutilayotgan daromadlar bilan solishtirish mumkin.
P3 Health Partners Inc. kimlar bilan raqobatlashadi
Sotuvga nisbatan forvard narx HCA Healthcare|Forvard P/S multiplikatori Tenet Healthcare Corp THC|FMS (Fresenius Medical Care Corp) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SOLV - Forvard P/S multiplikatori|EHC: Forvard P/S multiplikatori|UHS (Universal Health Services, Inc.) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati DaVita|Forvard narx/daromad multiplikatori RadNet Inc (RDNT)|Narxning kutilayotgan daromadga nisbati Option Care Health Inc|Forvard P/S multiplikatori Surgery Partners Group (SGRY)|Sotuvga nisbatan forvard narx Premier, Inc.|EYE - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx Progyny (PGNY)|ARDT: Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati Select Medical Corp (SEM)|Astrana Corp (ASTH) - Forvard P/S multiplikatori|MD (Pediatrix Corp) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati USPH|The Pennant Group (PNTG) - Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori Organogenesis Holdings Inc. ORGO|Narxning kutilayotgan daromadga nisbati Nutex Health Corp (NUTX)|Auna Corp - Narxning prognoz qilingan daromadga nisbati|SBC Medical Corp (SBC) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|EOLS - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati CYH|SKIN (BeautyHealth) - Narxning prognoz qilingan daromadga nisbati|MDWD - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati BTMD|JYNT (The Joint Corp.) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori docgo.com DCGO|Sotuvga nisbatan forvard narx Gain Therapeutics|Forvard P/S multiplikatori EUDA Health Holdings EUDA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati BMGL (Basel Medical Group Limited)|CLGN: Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati Cuprina Holdings (Cayman) Ltd|concordmedical.com (CCM) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori AMS|Forvard narx/daromad multiplikatori MEDIROM Healthcare Group Inc. (MRM)|ALBT (Avalon GloboCare) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati DHAI (DIH Group)|Longevity Health Holdings (XAGE) - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori newgenivf.com NIVF|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ATIP (ATI Physical Therapy Corp)|CMAX - Forvard P/S multiplikatori|Kindly MD Corp - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|ModivCare Corp (MODV) - Forvard P/S multiplikatori|NVOS: Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori SunLink Health Systems, Inc (SSY)|Narxning kutilayotgan daromadga nisbati IMAC Holdings
